Results 21 to 30 of about 156,165 (266)
Background: Duration of breastfeeding is an important health indicator of mother and child. There are various indirect epidemiological methods available to estimate the duration of breastfeeding from cross sectional data.
Anup Kumar +4 more
doaj +1 more source
Modified Weighted Kaplan-Meier Estimator
En muchos estudios médicos, la mayoría de los sujetos del estudio no llegan al evento de interés durante el período de estudio. En tales situaciones, el estimador de Kaplan Meier puede estimar las probabilidades de supervivencia para la observación censurada.
Mohammad Shafiq +2 more
openaire +2 more sources
Kaplan-Meier Survival Analysis: Practical Insights for Clinicians
This article aims to provide a guide that will help healthcare professionals and clinical researchers from all fields that deal with Kaplan-Meier curves.
António Pedro Gomes +4 more
doaj +1 more source
Background In the presence of dependent censoring even after stratification of baseline covariates, the Kaplan–Meier estimator provides an inconsistent estimate of risk.
Takuya Kawahara +2 more
doaj +1 more source
Background The difference in restricted mean survival time ( rmstD t ∗ $$ rmstD\left({t}^{\ast}\right) $$ ), the area between two survival curves up to time horizon t ∗ $$ {t}^{\ast } $$ , is often used in cost-effectiveness analyses to estimate the ...
Béranger Lueza +4 more
doaj +1 more source
Survival analysis (or time-to-event analysis) deals with data where the outcome of interest is the length of time until the occurrence of an event. This type of analysis is unique because the event may not occur in all participants (known as censoring ...
Priya Ranganathan +2 more
doaj +1 more source
ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman +17 more
wiley +1 more source
Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
BackgroundStudies providing more evidence to guide adjuvant chemotherapy decisions in elderly colon cancer patients are expected. MethodsWe obtained data from the Surveillance, Epidemiology and End Results (SEER) database between 2004 and 2012.
Xin Chen +8 more
doaj +1 more source
Robust bias estimation for Kaplan–Meier survival estimator with jackknifing [PDF]
17 pages, 3 figures, 5 tables. CRiSM working paper, Paper No.
Khan, Md. Hasinur Rahaman +1 more
openaire +3 more sources
Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors
ABSTRACT Introduction Pediatric relapsed or refractory (R/R) solid tumors carry a dismal prognosis, and postrelapse patient experiences are not well described. We present postrelapse outcomes, including number of R/R events and subsequent therapy regimens.
Matthew T. McEvoy +5 more
wiley +1 more source

